Clovis Oncology
CLVS
#9386
Rank
HK$91.75 M
Marketcap
HK$0.63
Share price
0.00%
Change (1 day)
-95.09%
Change (1 year)

Revenue for Clovis Oncology (CLVS)

Revenue in 2022 (TTM): HK$1.04 B

According to Clovis Oncology's latest financial reports the company's current revenue (TTM) is HK$1.03 B. In 2021 the company made a revenue of HK$1.15 B a decrease over the revenue in the year 2020 that were of HK$1.27 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clovis Oncology from 2010 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) HK$1.04 B-10.2%
2021 HK$1.15 B-9.07%
2020 HK$1.27 B14.52%
2019 HK$1.11 B49.12%
2018 HK$0.74 B72.23%
2017 HK$0.43 B71603.92%
2016 HK$0.6 M
2015 N/A-100%
2014 HK$0.10 B
2013 N/A
2012 N/A
2011 N/A
2010 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$20.17 B 1,845.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$382.99 B 36,836.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$433.73 B 41,729.49%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$674.86 B 64,984.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$428.72 B 41,246.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$303.40 B 29,160.64%๐Ÿ‡บ๐Ÿ‡ธ USA